BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1550778)

  • 1. Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists.
    Renesto P; Kadiri C; Chignard M
    Br J Haematol; 1992 Feb; 80(2):205-13. PubMed ID: 1550778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase potentiates cathepsin G-induced platelet activation.
    Selak MA
    Thromb Haemost; 1992 Nov; 68(5):570-6. PubMed ID: 1333649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils.
    Renesto P; Chignard M
    J Immunol; 1991 Apr; 146(7):2305-9. PubMed ID: 2005399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin inhibits neutrophil-induced platelet activation via cathepsin G.
    Ferrer-Lopez P; Renesto P; Prevost MC; Gounon P; Chignard M
    J Lab Clin Med; 1992 Mar; 119(3):231-9. PubMed ID: 1541873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation.
    Renesto P; Chignard M
    Blood; 1993 Jul; 82(1):139-44. PubMed ID: 8324217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
    Renesto P; Ferrer-Lopez P; Chignard M
    Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation: comparison with thrombin.
    Si-Tahar M; Renesto P; Falet H; Rendu F; Chignard M
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):401-8. PubMed ID: 8573071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism between interleukin-8 and tumor necrosis factor-alpha for neutrophil-mediated platelet activation.
    Si Tahar M; Renesto P; Balloy V; Chignard M
    Eur Cytokine Netw; 1994; 5(5):455-60. PubMed ID: 7880976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human neutrophil cathepsin G is a potent platelet activator.
    LaRosa CA; Rohrer MJ; Benoit SE; Rodino LJ; Barnard MR; Michelson AD
    J Vasc Surg; 1994 Feb; 19(2):306-18; discussion 318-9. PubMed ID: 7509416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation.
    Zhou W; Javors MA; Olson MS
    J Immunol; 1992 Sep; 149(5):1763-9. PubMed ID: 1506691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Ca2+ rise in human platelets induced by polymorphonuclear-leucocyte-derived cathepsin G.
    Molino M; Di Lallo M; de Gaetano G; Cerletti C
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):741-5. PubMed ID: 1471987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
    Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
    Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase 3. A neutrophil proteinase with activity on platelets.
    Renesto P; Halbwachs-Mecarelli L; Nusbaum P; Lesavre P; Chignard M
    J Immunol; 1994 May; 152(9):4612-7. PubMed ID: 8157974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products.
    Vercellotti GM; Moldow CF; Wickham NW; Jacob HS
    J Lipid Mediat; 1990; 2 Suppl():S23-30. PubMed ID: 1966817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion.
    Evangelista V; Piccardoni P; White JG; de Gaetano G; Cerletti C
    Blood; 1993 Jun; 81(11):2947-57. PubMed ID: 7684621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
    Shah BH; Rasheed H; Rahman IH; Shariff AH; Khan FL; Rahman HB; Hanif S; Saeed SA
    Exp Mol Med; 2001 Dec; 33(4):226-33. PubMed ID: 11795484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different requirement of intracellular calcium and protein kinase C for arachidonic acid release and serotonin secretion in cathepsin G-activated platelets.
    Rotondo S; Evangelista V; Manarini S; de Gaetano G; Cerletti C
    Thromb Haemost; 1997 Aug; 78(2):919-25. PubMed ID: 9268195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P; Chignard M
    J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.